Role of physiological levels of 4-hydroxynonenal on adipocyte biology: implications for obesity and metabolic syndrome

References

• Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, . PPAR gamma mediates highfat diet induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597–609.
   PubMed Web of Science ®Google Scholar
• Mlinar B, Marc J. New insights into adipose tissue dysfunction in insulin resistance.J Clin Chem Lab Med 2011;49:1925–1935.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289–312.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114: 1752–1161.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–820.
   PubMed Web of Science ®Google Scholar
• Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension?Proc Natl Acad Sci USA 1991;88:10045–10048.
   PubMed Web of Science ®Google Scholar
• Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546–2551.
   PubMed Web of Science ®Google Scholar
• Maddux BA, See W, Lawrence JC Jr.,Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 2001;50:404–410.
   PubMed Web of Science ®Google Scholar
• Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998;47: 1562–1569.
   PubMed Web of Science ®Google Scholar
• Shibata M, Hakuno F, Yamanaka D, Okajima H, Fukushima T, Hasegawa T, . Paraquat-induced oxidative stress represses phosphatidylinositol 3-kinase activities leading to impaired glucose uptake in 3T3-L1 adipocytes. J Biol Chem 2010; 285:20915–20925.
   PubMed Web of Science ®Google Scholar
• Grimsrud PA, Picklo MJ Sr.,Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4- hydroxynonenal. Mol Cell Proteomics 2007;6:624–637.
   PubMed Web of Science ®Google Scholar
• Benedetti A, Pompella A, Fulceri R, Romani A, Comporti M. Detection of 4-hydroxynonenal and other lipid peroxidation products in the liver of bromobenzene-poisoned mice. Biochim Biophys Acta 1986;876:658–666.
   PubMedGoogle Scholar
• Codreanu SG, Zhang B, Sobecki SM, Billheimer DD, Liebler DC. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol Cell Proteomics 2009; 8:670–680.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity the metabolic syndrome and associated vascular and neurodegenerative disorders. Exp Gerontol 2009; 44:625–633.
   PubMed Web of Science ®Google Scholar
• Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004; 37:937–945.
   PubMed Web of Science ®Google Scholar
• Ji C, Amarnath V, Pietenpol JA, Marnett LJ. 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem Res Toxicol 2001;14:1090–1096.
   PubMed Web of Science ®Google Scholar
• Cheng JZ, Singhal SS, Saini M, Singhal J, Piper JT, Van Kuijk FJ, . Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells. Arch Biochem Biophys 1999;372:29–36.
   PubMed Web of Science ®Google Scholar
• Kreuzer T, Grube R, Wutte A, Zarkovic N, Schaur RJ. 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells. Free Radic Biol Med 1998;25:42–49.
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 1993;11: 279–286.
   PubMed Web of Science ®Google Scholar
• Barrera G, Pizzimenti S, Dianzani MU. Lipid peroxidation: control of cell proliferation cell differentiation and cell death. Mol Aspects Med 2008;29:1–8.
   PubMed Web of Science ®Google Scholar
• Dwivedi S, Sharma A, Patrick B, Sharma R, Awasthi YC. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 2007;12:4–10.
   PubMed Web of Science ®Google Scholar
• Echtay KS, Brand MD.4‐hydroxy-2-nonenal and uncoupling proteins: an approach for regulation of mitochondrial ROS production.Redox Rep 2007;12:26–29.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Robbesyn F, Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004; 37:1694–1702.
   PubMed Web of Science ®Google Scholar
• Shearn CT, Smathers RL, Stewart BJ, Fritz KS, Galligan JJ, Hail N Jr.,Petersen DR. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition by 4-hydroxynonenal leads to increased Akt activation in hepatocytes. Mol Pharmacol 2011;79:941–952.
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785–1788.
   PubMed Web of Science ®Google Scholar
• Demozay D, Mas JC, Rocchi S, Van Obberghen E. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes 2008;57:1216–1226.
   PubMed Web of Science ®Google Scholar
• Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 1993;57(5 Suppl):779S–785S.
   Web of Science ®Google Scholar
• Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003;24:167–175.
   PubMedGoogle Scholar
• Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003;42:318–343.
   PubMed Web of Science ®Google Scholar
• Strohmaier H, Hinghofer-Szalkay H, Schaur RJ. Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J Lipid Mediat Cell Signal 1995;11:51–61.
   PubMedGoogle Scholar
• Syslova K, Kacer P, Kuzma M, Najmanova V, Fenclova Z, Vlckova S, . Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2477–2486.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Yamada S, Kashima M, Ihara Y, Yamada Y, Tanaka T, . Serum 4-hydroxy- 2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal 2000;2:681–685.
   PubMed Web of Science ®Google Scholar
• Shearn CT, Fritz KS, Reigan P, Petersen DR. Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells. Biochemistry 2011;50:3984–3996.
   PubMed Web of Science ®Google Scholar
• Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 1999;274:10595–10602.
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84–89.
   PubMed Web of Science ®Google Scholar
• Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:263–273.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev 2000;14:1293–1307.
   PubMed Web of Science ®Google Scholar
• Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002;147: 173–180.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29–33.
   PubMed Web of Science ®Google Scholar
• Nicklas BJ, Rogus EM, Colman EG, Goldberg AP. Visceral adiposity increased adipocyte lipolysis and metabolic dysfunction in obese postmenopausal women. Am J Physiol 1996;270: E72–78.
   Google Scholar
• Findeisen HM, Pearson KJ, Gizard F, Zhao Y, Qing H, Jones KL, . Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS One 2011; 6:e18532.
   PubMed Web of Science ®Google Scholar
• Wang Z, Dou X, Gu D, Shen C, Yao T, Nguyen V,et al.4-Hydroxynonenal differentially regulates adiponectin gene expression and secretion via activating PPARγ and accelerating ubiquitin-proteasome degradation. Mol Cell Endocrinol 2012;349:222–231.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ebenezer PJ, Dasuri K, Fernandez-Kim SO, Francis J, Mariappan N, . Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. Am J Physiol Endocrinol Metab 2011;301: E599–607.
   PubMed Web of Science ®Google Scholar
• Dasuri K, Zhang L, Ebenezer P, Fernandez-Kim SO, Bruce-Keller AJ, Szweda LI, Keller JN. Proteasome alterations during adipose differentiation and aging: links to impaired adipocyte differentiation and development of oxidative stress. Free Radic Biol Med 2011;51:1727–1735.
   Google Scholar
• Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004;10:355–361.
   PubMed Web of Science ®Google Scholar
• Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009;33:54–66.
   PubMed Web of Science ®Google Scholar
• Djian P, Roncari AK, Hollenberg CH. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture. J Clin Invest 1983;72: 1200–1208.
   PubMed Web of Science ®Google Scholar
• Karagiannides I, Tchkonia T, Dobson DE, Steppan CM, Cummins P, Chan G, . Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol 2001;280:R1772–1780.
   PubMed Web of Science ®Google Scholar
• Kirkland JL, Hollenberg CH, Gillon WS. Age anatomic site and the replication and differentiation of adipocyte precursors. Am J Physiol Cell Physiol 1990;258:C206–210.
   Web of Science ®Google Scholar
• Maury E, Brichard SM. Adipokine dysregulation adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1–16.
   PubMed Web of Science ®Google Scholar
• Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537–1545.
   PubMed Web of Science ®Google Scholar
• Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3–10.
   PubMed Web of Science ®Google Scholar
• Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007;10:142–148.
   PubMed Web of Science ®Google Scholar